TET2 and acute lymphoblastic leukemia: Whereas further experiments are required to determine the molecular underpinnings of 5-aza toxicity in TET2-silenced T-ALL cells, our results clearly identify TET2 as a potential tumor suppressor and, importantly, a therapeutic target in T-ALL.